Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia
Pantothenic acid (vitamin B5) is an essential trace nutrient required for the synthesis of coenzyme A (CoA). It has previously been shown that pantothenic acid is significantly decreased in multiple brain regions in both Alzheimer’s disease (ADD) and Huntington’s disease (HD). The current investigat...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/11/9/569 |
id |
doaj-c478ab4f1e094e158574b5baa876cff0 |
---|---|
record_format |
Article |
spelling |
doaj-c478ab4f1e094e158574b5baa876cff02021-09-26T00:40:40ZengMDPI AGMetabolites2218-19892021-08-011156956910.3390/metabo11090569Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease DementiaMelissa Scholefield0Stephanie J. Church1Jingshu Xu2Stefano Patassini3Nigel M. Hooper4Richard D. Unwin5Garth J. S. Cooper6Centre for Advanced Discovery & Experimental Therapeutics, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKCentre for Advanced Discovery & Experimental Therapeutics, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKCentre for Advanced Discovery & Experimental Therapeutics, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKSchool of Biological Sciences, Faculty of Science, University of Auckland, Private Bag 92 019, Auckland 1142, New ZealandDivision of Neuroscience & Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKCentre for Advanced Discovery & Experimental Therapeutics, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKCentre for Advanced Discovery & Experimental Therapeutics, Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9NT, UKPantothenic acid (vitamin B5) is an essential trace nutrient required for the synthesis of coenzyme A (CoA). It has previously been shown that pantothenic acid is significantly decreased in multiple brain regions in both Alzheimer’s disease (ADD) and Huntington’s disease (HD). The current investigation aimed to determine whether similar changes are also present in cases of Parkinson’s disease dementia (PDD), another age-related neurodegenerative condition, and whether such perturbations might occur in similar regions in these apparently different diseases. Brain tissue was obtained from nine confirmed cases of PDD and nine controls with a post-mortem delay of 26 h or less. Tissues were acquired from nine regions that show high, moderate, or low levels of neurodegeneration in PDD: the cerebellum, motor cortex, primary visual cortex, hippocampus, substantia nigra, middle temporal gyrus, medulla oblongata, cingulate gyrus, and pons. A targeted ultra–high performance liquid chromatography—tandem mass spectrometry (UHPLC-MS/MS) approach was used to quantify pantothenic acid in these tissues. Pantothenic acid was significantly decreased in the cerebellum (<i>p</i> = 0.008), substantia nigra (<i>p</i> = 0.02), and medulla (<i>p</i> = 0.008) of PDD cases. These findings mirror the significant decreases in the cerebellum of both ADD and HD cases, as well as the substantia nigra, putamen, middle frontal gyrus, and entorhinal cortex of HD cases, and motor cortex, primary visual cortex, hippocampus, middle temporal gyrus, cingulate gyrus, and entorhinal cortex of ADD cases. Taken together, these observations indicate a common but regionally selective disruption of pantothenic acid levels across PDD, ADD, and HD.https://www.mdpi.com/2218-1989/11/9/569pantothenic acidvitamin B5Parkinson’s disease dementiamass spectrometryAlzheimer’s diseaseHuntington’s disease |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Melissa Scholefield Stephanie J. Church Jingshu Xu Stefano Patassini Nigel M. Hooper Richard D. Unwin Garth J. S. Cooper |
spellingShingle |
Melissa Scholefield Stephanie J. Church Jingshu Xu Stefano Patassini Nigel M. Hooper Richard D. Unwin Garth J. S. Cooper Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia Metabolites pantothenic acid vitamin B5 Parkinson’s disease dementia mass spectrometry Alzheimer’s disease Huntington’s disease |
author_facet |
Melissa Scholefield Stephanie J. Church Jingshu Xu Stefano Patassini Nigel M. Hooper Richard D. Unwin Garth J. S. Cooper |
author_sort |
Melissa Scholefield |
title |
Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
title_short |
Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
title_full |
Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
title_fullStr |
Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
title_full_unstemmed |
Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia |
title_sort |
substantively lowered levels of pantothenic acid (vitamin b5) in several regions of the human brain in parkinson’s disease dementia |
publisher |
MDPI AG |
series |
Metabolites |
issn |
2218-1989 |
publishDate |
2021-08-01 |
description |
Pantothenic acid (vitamin B5) is an essential trace nutrient required for the synthesis of coenzyme A (CoA). It has previously been shown that pantothenic acid is significantly decreased in multiple brain regions in both Alzheimer’s disease (ADD) and Huntington’s disease (HD). The current investigation aimed to determine whether similar changes are also present in cases of Parkinson’s disease dementia (PDD), another age-related neurodegenerative condition, and whether such perturbations might occur in similar regions in these apparently different diseases. Brain tissue was obtained from nine confirmed cases of PDD and nine controls with a post-mortem delay of 26 h or less. Tissues were acquired from nine regions that show high, moderate, or low levels of neurodegeneration in PDD: the cerebellum, motor cortex, primary visual cortex, hippocampus, substantia nigra, middle temporal gyrus, medulla oblongata, cingulate gyrus, and pons. A targeted ultra–high performance liquid chromatography—tandem mass spectrometry (UHPLC-MS/MS) approach was used to quantify pantothenic acid in these tissues. Pantothenic acid was significantly decreased in the cerebellum (<i>p</i> = 0.008), substantia nigra (<i>p</i> = 0.02), and medulla (<i>p</i> = 0.008) of PDD cases. These findings mirror the significant decreases in the cerebellum of both ADD and HD cases, as well as the substantia nigra, putamen, middle frontal gyrus, and entorhinal cortex of HD cases, and motor cortex, primary visual cortex, hippocampus, middle temporal gyrus, cingulate gyrus, and entorhinal cortex of ADD cases. Taken together, these observations indicate a common but regionally selective disruption of pantothenic acid levels across PDD, ADD, and HD. |
topic |
pantothenic acid vitamin B5 Parkinson’s disease dementia mass spectrometry Alzheimer’s disease Huntington’s disease |
url |
https://www.mdpi.com/2218-1989/11/9/569 |
work_keys_str_mv |
AT melissascholefield substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT stephaniejchurch substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT jingshuxu substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT stefanopatassini substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT nigelmhooper substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT richarddunwin substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia AT garthjscooper substantivelyloweredlevelsofpantothenicacidvitaminb5inseveralregionsofthehumanbraininparkinsonsdiseasedementia |
_version_ |
1716870116334895104 |